Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur V. PRASHER |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS) / G. M. TAN in Journal of Neurodevelopmental Disorders, 6-1 (December 2014)
[article]
Titre : Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS) Type de document : Texte imprimé et/ou numérique Auteurs : G. M. TAN, Auteur ; F. BEACHER, Auteur ; Eileen DALY, Auteur ; J. HORDER, Auteur ; V. PRASHER, Auteur ; M. L. HANNEY, Auteur ; R. MORRIS, Auteur ; S. LOVESTONE, Auteur ; K. C. MURPHY, Auteur ; A. SIMMONS, Auteur ; D. G. MURPHY, Auteur Article en page(s) : p.42 Langues : Anglais (eng) Mots-clés : 1h mrs Alzheimer's disease Dementia Down syndrome Glutamate-glutamine (Glx) Hippocampus Intellectual disability Magnetic resonance spectroscopy Index. décimale : PER Périodiques Résumé : BACKGROUND: Down syndrome (DS), or trisomy 21, is one of the most common autosomal mutations. People with DS have intellectual disability (ID) and are at significantly increased risk of developing Alzheimer's disease (AD). The biological associates of both ID and AD in DS are poorly understood, but glutamate has been proposed to play a key role. In non-DS populations, glutamate is essential to learning and memory and glutamate-mediated excitotoxicity has been implicated in AD. However, the concentration of hippocampal glutamate in DS individuals with and without dementia has not previously been directly investigated. Proton magnetic resonance spectroscopy ((1)H MRS) can be used to measure in vivo the concentrations of glutamate-glutamine (Glx). The objective of the current study was to examine the hippocampal Glx concentration in non-demented DS (DS-) and demented DS (DS+) individuals. METHODS: We examined 46 adults with DS (35 without dementia and 11 with dementia) and 39 healthy controls (HC) using (1)H MRS and measured their hippocampal Glx concentrations. RESULTS: There was no significant difference in the hippocampal Glx concentration between DS+ and DS-, or between either of the DS groups and the healthy controls. Also, within DS, there was no significant correlation between hippocampal Glx concentration and measures of overall cognitive ability. Last, a sample size calculation based on the effect sizes from this study showed that it would have required 6,257 participants to provide 80% power to detect a significant difference between the groups which would indicate that there is a very low likelihood of a type 2 error accounting for the findings in this study. CONCLUSIONS: Individuals with DS do not have clinically detectable differences in hippocampal Glx concentration. Other pathophysiological processes likely account for ID and AD in people with DS. En ligne : http://dx.doi.org/10.1186/1866-1955-6-42 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=347
in Journal of Neurodevelopmental Disorders > 6-1 (December 2014) . - p.42[article] Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS) [Texte imprimé et/ou numérique] / G. M. TAN, Auteur ; F. BEACHER, Auteur ; Eileen DALY, Auteur ; J. HORDER, Auteur ; V. PRASHER, Auteur ; M. L. HANNEY, Auteur ; R. MORRIS, Auteur ; S. LOVESTONE, Auteur ; K. C. MURPHY, Auteur ; A. SIMMONS, Auteur ; D. G. MURPHY, Auteur . - p.42.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 6-1 (December 2014) . - p.42
Mots-clés : 1h mrs Alzheimer's disease Dementia Down syndrome Glutamate-glutamine (Glx) Hippocampus Intellectual disability Magnetic resonance spectroscopy Index. décimale : PER Périodiques Résumé : BACKGROUND: Down syndrome (DS), or trisomy 21, is one of the most common autosomal mutations. People with DS have intellectual disability (ID) and are at significantly increased risk of developing Alzheimer's disease (AD). The biological associates of both ID and AD in DS are poorly understood, but glutamate has been proposed to play a key role. In non-DS populations, glutamate is essential to learning and memory and glutamate-mediated excitotoxicity has been implicated in AD. However, the concentration of hippocampal glutamate in DS individuals with and without dementia has not previously been directly investigated. Proton magnetic resonance spectroscopy ((1)H MRS) can be used to measure in vivo the concentrations of glutamate-glutamine (Glx). The objective of the current study was to examine the hippocampal Glx concentration in non-demented DS (DS-) and demented DS (DS+) individuals. METHODS: We examined 46 adults with DS (35 without dementia and 11 with dementia) and 39 healthy controls (HC) using (1)H MRS and measured their hippocampal Glx concentrations. RESULTS: There was no significant difference in the hippocampal Glx concentration between DS+ and DS-, or between either of the DS groups and the healthy controls. Also, within DS, there was no significant correlation between hippocampal Glx concentration and measures of overall cognitive ability. Last, a sample size calculation based on the effect sizes from this study showed that it would have required 6,257 participants to provide 80% power to detect a significant difference between the groups which would indicate that there is a very low likelihood of a type 2 error accounting for the findings in this study. CONCLUSIONS: Individuals with DS do not have clinically detectable differences in hippocampal Glx concentration. Other pathophysiological processes likely account for ID and AD in people with DS. En ligne : http://dx.doi.org/10.1186/1866-1955-6-42 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=347 The Diagnosis of Affective and Psychotic Disorders in Adults with Autism: Seven Case Reports / D. CLARKE in Autism, 3-2 (June 1999)
[article]
Titre : The Diagnosis of Affective and Psychotic Disorders in Adults with Autism: Seven Case Reports Type de document : Texte imprimé et/ou numérique Auteurs : D. CLARKE, Auteur ; M. BAXTER, Auteur ; D. PERRY, Auteur ; V. PRASHER, Auteur Article en page(s) : p.149-164 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Seven men with autistic disorders developed mood disorders or psychotic illnesses during adult life. This association has also been described in several previous reports. Although no firm conclusions can be drawn on the basis of case reports alone, it appears that autistic disorders may increase vulnerability to such psychoses. Possible reasons for the association are discussed, as is treatment. En ligne : http://dx.doi.org/10.1177/1362361399003002005 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=208
in Autism > 3-2 (June 1999) . - p.149-164[article] The Diagnosis of Affective and Psychotic Disorders in Adults with Autism: Seven Case Reports [Texte imprimé et/ou numérique] / D. CLARKE, Auteur ; M. BAXTER, Auteur ; D. PERRY, Auteur ; V. PRASHER, Auteur . - p.149-164.
Langues : Anglais (eng)
in Autism > 3-2 (June 1999) . - p.149-164
Index. décimale : PER Périodiques Résumé : Seven men with autistic disorders developed mood disorders or psychotic illnesses during adult life. This association has also been described in several previous reports. Although no firm conclusions can be drawn on the basis of case reports alone, it appears that autistic disorders may increase vulnerability to such psychoses. Possible reasons for the association are discussed, as is treatment. En ligne : http://dx.doi.org/10.1177/1362361399003002005 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=208